A Rare Case of ALK-Positive Large B-Cell Lymphoma with CD33 Expression
Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK+ LBCL) is a very rare and aggressive subtype of diffuse large B-cell lymphoma characterized by ALK rearrangement. Immunophenotypically, the tumor cells are typically negative for common B-cell markers, T-cell markers, and CD30; however,...
Saved in:
Main Authors: | Jessica Corean, K. David Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2018/5320590 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ALK-Positive Anaplastic Large Cell Lymphoma: A Diagnostic Dilemma for the Otolaryngologist in a Resource Poor Setting
by: Nicholas Figaro, et al.
Published: (2021-01-01) -
Alectinib combined with VRCD and BV monoclonal antibody for the treatment of ALK-positive large B-cell lymphoma: a case report and literature review
by: Hongxia Wang, et al.
Published: (2025-01-01) -
CD7-Positive Diffuse Large B-Cell Lymphoma Presenting as an Intranasal Tumor
by: Kazuaki Teshima, et al.
Published: (2020-01-01) -
CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type
by: Alexandra Papoudou-Bai, et al.
Published: (2019-01-01) -
Systemic Capillary Leak Syndrome as an Initial Presentation of ALK-Negative Anaplastic Large Cell Lymphoma
by: Laura S. Lourdes, et al.
Published: (2012-01-01)